NEWS

Pharmaceutical Industry news helps our clients to give competitive edge to their customers and also latest pharmaceutical industry news assists them in gaining updated knowledge. We bring you Global Pharmaceutical news about acquisitions, project undertakings, business and marketing, subjects, and industry related subjects, written in a professional, unbiased and thought-provoking format. Our international pharmaceutical News will help you enhance your business knowledge and productivity.

news

DBV Technologies SA said on Friday its peanut allergy treatment did not meet the main goal in a highly anticipated late-stage study, sending its U.S.-listed shares sharply down. Nasdaq-listed shares of the French drug developer plunged 60.5 percent to $19 in extended trading. The trial, which tested a 250 microgram…

news

Novo Nordisk A/S’s new diabetes drug semaglutide is effective, reasonably safe and should be approved, an advisory panel to the U.S. Food and Drug Administration concluded on Wednesday. The panel voted 16-0 with one abstention in favor of the drug being approved. It would compete with others in a class…

news

Swiss drugmaker Novartis is to cut 450 jobs in the United States over the next two years as it gradually shuts a generics manufacturing plant in Colorado and discontinues some products in the face of intense price pressures. “To remain competitive in the U.S., Novartis will discontinue or divest limited…

news

Celgene Corp said it would abandon testing a drug to treat Crohn’s disease, in a major setback to the U.S. biotechnology company’s pipeline amid attempts to lower dependence on its mainstay Revilimid. The company’s shares fell 6.4 percent to $136.96 in extended trading on Thursday. Celgene said it would stop…

news

Johnson & Johnson on Tuesday won the reversal of a $72 million verdict in favor of the family of a woman whose death from ovarian cancer they claimed stemmed from her use of the company’s talc-based products like Johnson’s Baby Powder. The Missouri Court of Appeals, Eastern District said that…

news

Takeda Pharmaceutical Company Limited (TSE: 4502) and HemoShear Therapeutics, LLC, a privately held biotechnology company, today announced a partnership to discover and develop novel therapeutics for liver diseases, including nonalcoholic steatohepatitis (NASH). “The ability to study pathophysiology in a human multi-cell system is crucial for our understanding of disease and…

news

An experimental cancer drug discovered by Hutchison China MediTech has demonstrated promising activity in shrinking tumors in lung cancer patients whose disease had worsened following treatment with approved medicines. The treatment, which Hutchison China MediTech or “Chi-Med” is developing with AstraZeneca, is one of a new wave of innovative medicines…

news

Regeneron Pharmaceuticals Inc and Sanofi SA said on Monday their drug to treat inflammation in the esophagus, mainly caused by food allergies, met the main goal of a mid-stage study. The drug, dupilumab, was statistically significant in improving the ability to swallow in adults with moderate-to-severe eosinophilic esophagitis, when compared…

news

Johnson & Johnson said on Friday it has received an expanded U.S. approval for its blockbuster psoriasis drug Stelara to treat adolescent patients aged 12 and over with moderate to severe cases of the unsightly skin condition. Stelara was already approved to treat adults with the condition, a chronic, autoimmune…

news

Canadian health regulators have approved GlaxoSmithKline’s key shingles vaccine, the company said on Friday. Shingrix, the British pharma company’s shingles vaccine for people aged 50 years or older, was unanimously recommended for approval by a U.S. Food and Drug Administration (FDA) advisory panel last week. Older people are most at…

loadmore..